DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Natural killer cell mediated cytotoxicity	R-HSA-5218921	map04650	suxibuzone	5362	drug-path
Antigen processing and presentation	R-HSA-1236975	map04612	suxibuzone	5362	drug-path
Olfactory transduction	R-HSA-9751605	map04740	suxibuzone	5362	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	suxibuzone	5362	drug-path
Phosphatidylinositol signaling system	R-HSA-1280215	map04070	suxibuzone	5362	drug-path
B cell receptor signaling pathway	R-HSA-983705	map04662	suxibuzone	5362	drug-path
Amyotrophic lateral sclerosis (ALS)	Q8NDH6-2	0	suxibuzone	5362	drug-path
VEGF signaling pathway	R-HSA-194138	map04370	suxibuzone	5362	drug-path
MAPK signaling pathway	R-HSA-9652817	map04010	suxibuzone	5362	drug-path
Homologous recombination	R-HSA-5685942	map03440	SB-203580	4754	drug-path
Alzheimer's disease	R-HSA-1643685	0	SB-203580	4754	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	SB-203580	4754	drug-path
Huntington's disease	R-HSA-1643685	0	SB-203580	4754	drug-path
Olfactory transduction	R-HSA-9751605	map04740	SB-203580	4754	drug-path
Tight junction	R-HSA-2134514	map04530	SB-203580	4754	drug-path
Adipocytokine signaling pathway	R-HSA-168638	map04920	SB-203580	4754	drug-path
Jak-STAT signaling pathway	R-HSA-168638	map04630	SB-203580	4754	drug-path
Chemokine signaling pathway	R-HSA-168638	map04062	SB-203580	4754	drug-path
Parkinson's disease	R-HSA-1643685	0	SB-203580	4754	drug-path
Cardiac muscle contraction	R-HSA-397014	map04260	SB-203580	4754	drug-path